Bai H, Wang W, Zhou F, Yang D, Li R
Cancer Manag Res. 2024; 16:73-86.
PMID: 38318097
PMC: 10840531.
DOI: 10.2147/CMAR.S427680.
Yang Z, Zhang X, Bai X, Xi X, Liu W, Zhong W
Cancer Sci. 2024; 115(3):734-751.
PMID: 38233340
PMC: 10921012.
DOI: 10.1111/cas.16063.
Deng C, Tang M, Pan X, Liu Z
World J Clin Cases. 2023; 11(19):4670-4676.
PMID: 37469725
PMC: 10353496.
DOI: 10.12998/wjcc.v11.i19.4670.
Tan S, Pumpalova Y, Rogers A, Bhatt K, Herbst C, Ruff P
Cancer Med. 2023; 12(14):15515-15529.
PMID: 37318753
PMC: 10417185.
DOI: 10.1002/cam4.6199.
Griswold D, Venturini S, Carney N, Rubiano A, Hutchinson P, Kolias A
BMJ Open. 2022; 12(9):e059603.
PMID: 36171036
PMC: 9528583.
DOI: 10.1136/bmjopen-2021-059603.
The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis.
Zhao N, Xu H, Zhou D, Xu X, Ge W, Cao D
J Gastrointest Oncol. 2022; 13(4):1772-1781.
PMID: 36092324
PMC: 9459190.
DOI: 10.21037/jgo-22-683.
Efficacy and safety of raltitrexed plus S-1 regorafenib in patients with refractory metastatic colorectal cancer: a real-world propensity score matching study.
Zhou Y, Wang J, Li Q, He Y, Li L, Liu R
Therap Adv Gastroenterol. 2022; 15:17562848221098246.
PMID: 35601804
PMC: 9121501.
DOI: 10.1177/17562848221098246.
Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors.
Zheng Q, Yu X, Zhang M, Zhang S, Guo W, He Y
Front Cell Dev Biol. 2022; 9:750084.
PMID: 34988073
PMC: 8721001.
DOI: 10.3389/fcell.2021.750084.
Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in Apc mice.
Yang K, Zhu J, Luo H, Yu S, Wang L
Int J Immunopathol Pharmacol. 2021; 35:20587384211038345.
PMID: 34586888
PMC: 8485261.
DOI: 10.1177/20587384211038345.
Efficacy and Safety of Regorafenib Monotherapy among Patients with Previously Treated Metastatic Colorectal Cancer in a Chinese Population: A Real-World Exploratory Study.
Wang R, Zhao Y, Wang A, Wang Y, Yin Z, Chen K
Int J Gen Med. 2021; 14:5363-5373.
PMID: 34522132
PMC: 8434851.
DOI: 10.2147/IJGM.S325545.
MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B/HOXC4/PD-L1 Axis.
Liu L, Yu T, Jin Y, Mai W, Zhou J, Zhao C
Front Cell Dev Biol. 2021; 9:629893.
PMID: 33732698
PMC: 7959841.
DOI: 10.3389/fcell.2021.629893.
Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis.
Sun T, Liu Z, Zhang R, Ma S, Lin T, Li Y
Onco Targets Ther. 2020; 13:2957-2972.
PMID: 32308428
PMC: 7156234.
DOI: 10.2147/OTT.S232839.
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
Kurppa K, Liu Y, To C, Zhang T, Fan M, Vajdi A
Cancer Cell. 2020; 37(1):104-122.e12.
PMID: 31935369
PMC: 7146079.
DOI: 10.1016/j.ccell.2019.12.006.
ATG3, a Target of miR-431-5p, Promotes Proliferation and Invasion of Colon Cancer via Promoting Autophagy.
Huang W, Zeng C, Hu S, Wang L, Liu J
Cancer Manag Res. 2019; 11:10275-10285.
PMID: 31849517
PMC: 6911302.
DOI: 10.2147/CMAR.S226828.
AK001058 promotes the proliferation and migration of colorectal cancer cells by regulating methylation of ADAMTS12.
Zheng S, Lin F, Zhang M, Fu J, Ge X, Mu N
Am J Transl Res. 2019; 11(9):5869-5878.
PMID: 31632555
PMC: 6789239.
MicroRNA 214 inhibits adipocyte enhancer-binding protein 1 activity and increases the sensitivity of chemotherapy in colorectal cancer.
Li S, Li C, Fang Z
Oncol Lett. 2019; 17(1):55-62.
PMID: 30655737
PMC: 6313171.
DOI: 10.3892/ol.2018.9623.
Radiomics in Oncological PET/CT: Clinical Applications.
Lee J, Lee S
Nucl Med Mol Imaging. 2018; 52(3):170-189.
PMID: 29942396
PMC: 5995782.
DOI: 10.1007/s13139-017-0500-y.
Palliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review.
Xu M, Su D, DeBoer R, Garcia M, Tahir P, Anderson W
J Cancer Educ. 2017; 34(2):205-215.
PMID: 29264703
DOI: 10.1007/s13187-017-1310-8.
Up-regulation of CIT promotes the growth of colon cancer cells.
Wu Z, Zhu X, Xu W, Zhang Y, Chen L, Qiu F
Oncotarget. 2017; 8(42):71954-71964.
PMID: 29069760
PMC: 5641103.
DOI: 10.18632/oncotarget.18615.
Upregulation of Yes-associated protein and transcriptional co-activator with PDZ-binding motif influences the behavior of LOVO human colon adenocarcinoma cells.
Li Y, Li L, Zhu M, Ye L, Yang Q
Exp Ther Med. 2017; 14(4):3831-3835.
PMID: 29042987
PMC: 5639388.
DOI: 10.3892/etm.2017.4962.
